Page 28 - GTM-3-1

Global Translational Medicine Role of HTS in cancer therapeutics

135. Dalton W. Detection of multidrug resistance 146. Van Keymeulen A, Lee MY, Ousset M, et al. Reactivation
gene expression in multiple myeloma. Leukemia. of multipotency by oncogenic PIK3CA induces breast
1997;11(7):1166‑1169. tumour heterogeneity. Nature. 2015;525(7567):119‑123.
doi: 10.1038/sj.leu.2400724 doi: 10.1038/nature14665
136. Susa M, Choy E, Yang C, et al. Multidrug resistance reversal 147. Katoh M. Canonical and non‑canonical WNT signaling in
agent, NSC77037, identified with a cell‑based screening cancer stem cells and their niches: Cellular heterogeneity,
assay. J Biomol Screen. 2010;15(3):287‑296. omics reprogramming, targeted therapy and tumor
plasticity (Review). Int J Oncol. 2017;51(5):1357‑1369.
doi: 10.1177/1087057109359422
doi: 10.3892/ijo.2017.4129
137. Winter SS, Lovato DM, Khawaja HM, et al. High‑throughput
screening for daunorubicin-mediated drug resistance 148. Zheng YW, Nie YZ, Taniguchi H. Cellular reprogramming
identifies mometasone furoate as a novel ABCB1‑reversal and hepatocellular carcinoma development. World J
agent. J Biomol Screen. 2008;13(3):185‑193. Gastroenterol. 2013;19(47):8850‑8860.
doi: 10.1177/1087057108314610 doi: 10.3748/wjg.v19.i47.8850
138. Duan Z, Choy E, Hornicek FJ. NSC23925, identified in 149. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat
a high-throughput cell-based screen, reverses multidrug Genet. 1999;21(2):163‑167.
resistance. PLoS One. 2009;4(10):e7415. doi: 10.1038/5947
doi: 10.1371/journal.pone.0007415 150. Wang D, Garcia‑Bassets I, Benner C, et al. Reprogramming
139. Ivnitski‑Steele I, Larson RS, Lovato DM, et al. High‑ transcription by distinct classes of enhancers functionally
throughput flow cytometry to detect selective inhibitors defined by eRNA. Nature. 2011;474(7351):390‑394.
of ABCB1, ABCC1, and ABCG2 transporters. Assay Drug doi: 10.1038/nature10006
Dev Technol. 2008;6(2):263‑276.
151. Li HF, Keeton A, Vitolo M, et al. A high‑throughput screen
doi: 10.1089/adt.2007.107 with isogenic PTEN+/+ and PTEN-/- cells identifies
140. Gurdon JB, Elsdale TR, Fischberg M. Sexually mature CID1340132 as a novel compound that induces apoptosis
individuals of Xenopus laevis from the transplantation of in PTEN and PIK3CA mutant human cancer cells.
single somatic nuclei. Nature. 1958;182(4627):64‑65. J Biomol Screen. 2011;16(4):383‑393.

doi: 10.1038/182064a0 doi: 10.1177/1087057110397357
141. Hass R, von der Ohe J, Ungefroren H. The intimate 152. Qin L, Yin YT, Zheng FJ, et al. WNT5A promotes
relationship among EMT, MET and TME: AT stemness characteristics in nasopharyngeal carcinoma
(ransdifferentiation) E (nhancing) M (ix) to be exploited cells leading to metastasis and tumorigenesis. Oncotarget.
for therapeutic purposes. Cancers. 2020;12(12):3674. 2015;6(12):10239‑10252.
doi: 10.3390/cancers12123674 doi: 10.18632/oncotarget.3518
142. Saito S, Lin YC, Nakamura Y, et al. Potential application of 153. Ewan K, Pajak B, Stubbs M, et al. A useful approach to
cell reprogramming techniques for cancer research. Cell identify novel small-molecule inhibitors of Wnt-dependent
Mol Life Sci. 2019;76:45‑65. transcription. Cancer Res. 2010;70(14):5963‑5973.
doi: 10.1158/0008‑5472.Can‑10‑1028
doi: 10.1007/s00018‑018‑2924‑7
154. Bialkowska AB, Yang VW. High‑throughput screening
143. Welch DR. Tumor heterogeneity-a “contemporary
concept” founded on historical insights and predictions. strategies for targeted identification of therapeutic
Cancer Res. 2016;76(1):4‑6. compounds in colorectal cancer. Future Oncol.
2012;8(3):259‑272.
doi: 10.1158/0008‑5472.CAN‑15‑3024
doi: 10.2217/fon.12.19
144. Denny SK, Yang D, Chuang CH, et al. Nfib promotes
metastasis through a widespread increase in chromatin 155. Lepourcelet M, Chen YNP, France DS, et al. Small‑
molecule antagonists of the oncogenic Tcf/β-catenin
accessibility. Cell. 2016;166(2):328‑342.
protein complex. Cancer Cell. 2004;5(1):91‑102.
doi: 10.1016/j.cell.2016.05.052
doi: 10.1016/S1535‑6108(03)00334‑9
145. Teng S, Li YE, Yang M, et al. Tissue‑specific transcription
reprogramming promotes liver metastasis of colorectal 156. Yu W, Ma Y, Shankar S, Srivastava RK. SATB2/β‑catenin/
TCF‑LEF pathway induces cellular transformation by
cancer. Cell Res. 2020;30(1):34‑49.
generating cancer stem cells in colorectal cancer. Sci
doi: 10.1038/s41422‑019‑0259‑z Rep. 2017;7(1):10939.

Volume 3 Issue 1 (2024) 20 https://doi.org/10.36922/gtm.2448